|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Feb―11 |
PDBe-KB COVID-19 data portal - supporting rapid coronavirus research |
Sameer Velankar |
2 |
[GO] |
2022―Feb―11 |
3DBionotes Covid-19 edition |
José Ramon Macias, Ruben Sanchez-Garcia, Pablo Conesa, Erney Ramirez-Aportela, Marta Martinez Gonzalez, Carlos Wert-Carvajal, et al. (+6) Alberto M. Parra-Perez, Joan Segura Mora, Sam Horrell, Andrea Thorn, Carlos O. S. Sorzano, Jose Maria Carazo |
3 |
[GO] |
2022―Feb―11 |
The Argentinian Crystal Growing Contest and other educational activities in Argentina during the COVID-19 pandemic |
Sebastián Klinke, Valeria Cintia Fuertes, Vanina Gisela Franco, Clarisa Ester Alvarez, Diego Germán Lamas |
4 |
[GO] |
2022―Feb―11 |
Crystallography schools and other educational activities in Latin America during the COVID-19 pandemic |
Diego Germán Lamas |
5 |
[GO] |
2022―Feb―11 |
University remote teaching in crystal chemistry during the COVID-19 pandemic: positive and negative aspects |
Olga V. Grineva |
6 |
[GO] |
2022―Feb―11 |
Structural basis of mRNA cap modification by SARS-CoV-2: role of metal ions and implications for COVID-19 severity by emerging variants |
Yogesh K. Gupta, Thiruselvam Viswanathan, Anurag Misra, Siu-Hong Chan, Shan Qi, Shailee Arya, et al. (+2) Nan Dai, Luis Martinez-Sobrido |
7 |
[GO] |
2022―Feb―11 |
Targeting COVID-19 viral enzymes in an evolving landscape of publishing and peer review |
James Fraser |
8 |
[GO] |
2022―Feb―11 |
A structure-guided taxonomicbased approach to the design of broad-spectrum coronavirus protease inhibitors |
Andrew D. Mesecar, Sarah E. St John, Emma K. Lendy, Brandon J. Anson, Mackenzie E. Chapman, Arun K. Ghosh |
9 |
[GO] |
2022―Feb―11 |
The Coronavirus Structural Task Force |
Andrea Thorn |
10 |
[GO] |
2022―Feb―11 |
Validation of cryo-EM structures of SARS-CoV-2 and mapping genomic mutations |
Sony Malhotra, Martyn Winn, Agnel Praveen Joseph |
11 |
[GO] |
2022―Feb―11 |
Crystallographic fragment screening of SARS-CoV-2 drug discovery targets |
Daren Fearon, Alice Douangamath, Ailsa Powell, Alex Dias, Anthony Aimon, Jose Brandao-Neto, et al. (+5) Louise Dunnett, Rachael Skyner, Tyler Gorrie-Stone, Warren Thompson, Frank von Delft |
12 |
[GO] |
2022―Feb―11 |
Structural studies towards the development of an oral main protease (Mpro) inhibitor to treat SARS-CoV-2 infection |
Joanne Lemieux, Muhammad Bashir Khan, Jimmy Lu, Elena Arutyunova, James Nieman, D. Lorne Tyrrell, Howard S. Young |
13 |
[GO] |
2022―Feb―11 |
Fragment-based drug discovery of SARS-CoV-2 main protease |
Weixiao Song, Sen Li, Ah Wing Edith Chan, Alun Coker |
14 |
[GO] |
2022―Feb―11 |
A crystallographic snapshot of SARS-CoV-2 main protease maturation process |
Gabriela D. Noske, Aline Minali Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, Gustavo M. A. Lima, Higor V. D. Rosa, et al. (+6) Humberto D. Pereira, Ana C. M. Zeri, Andrey F. Z. Nascimento, Marjorie C. L. C. Freire, Glaucius Oliva, Andre S. Godoy |
15 |
[GO] |
2022―Feb―11 |
The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro) |
Ali Ebrahim, Blake T. Riley, Desigan Kumaran, Babak Andi, Martin R. Fuchs, Sean McSweeney, Daniel A. Keedy |
16 |
[GO] |
2022―Feb―11 |
Co-crystallization of hepatitis C virus NS3/4A inhibitors and SARS-CoV-2 main protease using high-density acoustic droplet ejection (ADE) |
Babak Andi, Dale F. Kreitler, Desigan Kumaran, Alexei S. Soares, Jantana Keereetaweep, Jean Jakoncic, et al. (+4) Wuxian Shi, Martin R. Fuchs, John Shanklin, Sean McSweeney |
17 |
[GO] |
2022―Feb―11 |
Structure of SARS-CoV-2 papain-like protease PLpro reveals a framework for antiviral inhibitor design |
Vasundara Srinivasan, Nadine Werner, Sven Falke, Hévilla Brognaro, Sebastian Günther, Patrick Y. A. Reinke, et al. (+3) Iqbal Choudhary, Alke Meents, Christian Betzel |
18 |
[GO] |
2022―Feb―11 |
Transient complexes of the Nsp7, Nsp8 and Nsp12 in SARS-CoV-2 replication transcription complex |
Greg Hura |
19 |
[GO] |
2022―Feb―11 |
Investigation of furin inhibition to block SARS-CoV-2 spike protein cleavage and structural stability via molecular docking and molecular dynamics simulations |
Jaganathan Ramakrishnan, Archana Chinnamadhu, Kumaradhas Poomani |
20 |
[GO] |
2022―Feb―11 |
Enhanced peer review - rebuilding early SARS-CoV-2 structures in ISOLDE |
Tristan Ian Croll |
21 |
[GO] |
2022―Feb―11 |
Structural basis of SARS-CoV-2 translational shutdown and programmed ribosomal frameshifting |
Nenad Ban |
22 |
[GO] |
2022―Feb―11 |
Neutron crystallography for drug design targeting SARS-CoV-2 viral proteins |
Andrey Kovalevsky, Daniel Kneller, Leighton Coates |
23 |
[GO] |
2022―Feb―11 |
Integrating a discovery-based remote/hybrid crystallography laboratory module into an undergraduate teaching laboratory during the pandemic |
Joe Tanski |
24 |
[GO] |
2022―Feb―11 |
The role of structural biology in pandemic's puzzles: amino acids and short peptides as key players |
Joanna Bojarska, Vasso Apostolopous, John Matsoukas, Jack Feehan, Harry Ridgway, Piotr Zielenkiewicz, Wojciech M. Wolf |
25 |
[GO] |
2022―Feb―11 |
Learning in 3D with Pymol and Proteopedia during a pandemic: enzyme catalysis and conformational change |
Roderico Acevedo, Karsten W. Theis |
26 |
[GO] |
2021―Oct―21 |
A blended learning approach for a crystallography-based undergraduate practical (under COVID-19 restrictions) |
Peter Horton, Simon Coles |
27 |
[GO] |
2021―Oct―21 |
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity |
Michael Joyce |
28 |
[GO] |
2021―Oct―21 |
Bioinformatics and 3D structural analysis of the coronavirus main protease active site |
Amy Wu Wu, Mickayla Bacorn, Mary-Agnes Balogun, Cassandra Olivas, Christine Zardecki, Sagar Khare, et al. (+2) Stephen Burley, Joseph Lubin |
29 |
[GO] |
2021―Oct―21 |
Biochemical analysis and review of the active site evolution of SARS-CoV-2 and other coronaviruses |
Mickayla Bacorn |
30 |
[GO] |
2021―Oct―21 |
A global consortium, next-generation SARS-CoV-2 antibody therapeutics and stabilized spike |
Erica Saphire |
31 |
[GO] |
2021―Oct―21 |
Direct visualization of SARS-CoV-2 main protease electrostatics using neutron crystallography |
Daniel Kneller, Stephanie Galanie, Gwyndalyn Phillips, Leighton Coates, Andrey Kovalevsky |
32 |
[GO] |
2021―Oct―21 |
Mg2+ and Mn2+ coordinate Cap-0-RNA to position substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 |
Monica R. Lemus, George Minasov, Ludmilla Shuvalova, Nicole L. Inniss, Joseph S. Brunzelle, Courtney M. Daczkowski, et al. (+3) Paul Hoover, Andrew D. Mesecar, Karla J. F. Satchell |
33 |
[GO] |
2021―Oct―21 |
Understanding the active site of the SARS-CoV-2 papain-like protease (PLPro) |
Mary-Agnes Balogun, Amy Wu Wu, Mickayla Bacorn, Cassandra Olivas, Christine Zardecki, Joseph Lubin, et al. (+2) Sagar Khare, Stephen Burley |
34 |
[GO] |
2021―Oct―21 |
Deploying high-throughput protein crystallography-based drug discovery platforms to establish a structure-based drug discovery system for SARS-CoV-2 proteins |
Debanu Das |
35 |
[GO] |
2021―Oct―21 |
Structures of synthetic nanobodies in complex with SARS-CoV-2 spike or receptor-binding domain provide insights for developing therapeutics and vaccines |
Jiansheng Jiang, Javeed A. Dhobi, Kannan Natarajan, Lisa F. Boyd, Rick Huang, Allison Zeher, David H. Margulies |
36 |
[GO] |
2021―May―11 |
Mapping COVID-19 mutations in 3D: how SARS-CoV-2 has evolved during the first 6 months of the global pandemic |
Aaliyah Khan, Christine Zardecki, Stephen Burley, Sagar Khare |
37 |
[GO] |
2021―May―11 |
Delving into COVID-19 'seams': examining the structural fabric of SARS-CoV-2 |
Luz Alfaro, Christine Zardecki, Sagar Khare, Stephen Burley |
38 |
[GO] |
2021―May―11 |
Structural insights into the feline coronavirus drug GC376, which inhibits the main protease of SARS-CoV-2 and blocks virus replication |
Joanne Lemieux, Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, et al. (+8) Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas |
39 |
[GO] |
2021―May―11 |
Structural analysis of severe acute respiratory syndrome coronavirus-2 proteins: exploring mutations in Nsp13 |
Brea Tinsley, Stephen Burley, Christine Zardecki, Sagar Khare |
40 |
[GO] |
2021―May―11 |
Protein Data Bank in the time of coronavirus: how open-access 3D structures are enabling research and development in fundamental biology, biomedicine, biotechnology and drug discovery as we confront the global SARS-CoV-2 pandemic |
Stephen Burley |
41 |
[GO] |
2021―May―11 |
Structural basis of recognition of SARS-CoV-2 by neutralizing antibodies isolated from convalescent patients |
Ian Wilson, Meng Yuan, Nicholas C. Wu, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu |
42 |
[GO] |
2021―May―11 |
Crowdsourcing inhibitor discovery against the SARS-CoV-2 main protease |
Nir London |
43 |
[GO] |
2021―May―11 |
Understanding the evolution of SARS-CoV-2 non-structural protein 15 (Nsp15) in three dimensions (3D) |
Sophia Staggers, Christine Zardecki, Sagar Khare, Stephen Burley |
44 |
[GO] |
2021―May―11 |
Crystallography of SARS-CoV-2 non-structural proteins |
Andrzej Joachimiak, Changsoo Chang, Michael Endres, Robert Jedrzejczak, Youngchang Kim, Natalia Maltseva, et al. (+6) Karolina Michalska, Jerzy Osipiuk, Lucy Stols, Kemin Tan, Christine Tesar, Mateusz Wilamowski |
45 |
[GO] |
2021―May―11 |
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes |
Jason McLellan |